Levomilnacipran ameliorates lipopolysaccharide-induced depression-like behaviors and suppressed the TLR4/Ras signaling pathway
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110595 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Shuhan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Pro…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Levomilnacipran. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Technology Research and Development Program of Shandong, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Themen: Depression
Abstract (Originalsprache)
Levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, has been reported to have anti-depressive effects. However, the detailed mechanisms underlying these effects are still unclear. This study aimed to investigate the antidepressant mechanisms of levomilnacipran to discover new perspectives on the treatment of depression in male rats. Intraperitoneal injection of lipopolysaccharide (LPS) was used to induce depressive behaviors in rats. Activation of microglia and apoptosis of neurons verified by immunofluorescence. Inflammatory related proteins and neurotrophic related proteins were verified by immunoblotting. The mRNA expression of apoptosis markers was verified by real-time quantitative PCR. Finally, electron microscopy analysis was used to observe the ultrastructural pathology of neuron. Here, we found that the anti-depression and anti-anxiety effects of levomilnacipran in the LPS-induced rat model of depression was resulted from the suppression of neuroinflammation and neuronal apoptosis within prefrontal cortex of rats. Furthermore, we found that levomilnacipran could decrease the number of microglia and suppress its activation in prefrontal cortex of rats. This effect may be mediated by suppressing the TLR4/NF-κB and Ras/p38 signaling pathways. In addition, levomilnacipran plays a neuroprotective role by increasing the expression of neurotrophic factors. Taken together, these results suggest that levomilnacipran exerts antidepressant effects by attenuating neuroinflammation to inhibit the damage in central nervous system and plays a neuroprotective role to improve depressive behaviors. These findings suggest that suppression of neuroinflammation in prefrontal cortex could ameliorate depressive behavioral disorder of rats induced by LPS, which provided a new perspective for the treatment of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China.
- Department of Radiology, Qilu Hospital of Shandong University, 107 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China. Electronic address: jianwencheng@hotmail.com.
- Department of Physiology, Shandong University, School of Basic Medical Sciences, Cheeloo College of Medicine, 44 Wenhuaxilu Road, Jinan, Shandong Province 250012, PR China; Shandong Provincial Key Laboratory of Mental D…
Förderung
- Key Technology Research and Development Program of Shandong
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, S., Zhu, Z., Lan, T., Wu, Y., Li, Y., Wang, C., Jian, W., & Yu, S. Y. (2023). Levomilnacipran ameliorates lipopolysaccharide-induced depression-like behaviors and suppressed the TLR4/Ras signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110595
Vancouver
Li S, Zhu Z, Lan T, Wu Y, Li Y, Wang C, et al. Levomilnacipran ameliorates lipopolysaccharide-induced depression-like behaviors and suppressed the TLR4/Ras signaling pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110595
BibTeX
@article{Li2023,
author = {Li, Shuhan and Zhu, Zhanpeng and Lan, Tian and Wu, Yuhan and Li, Ye and Wang, Changmin and Jian, Wencheng and Yu, Shu Yan},
title = {Levomilnacipran ameliorates lipopolysaccharide-induced depression-like behaviors and suppressed the TLR4/Ras signaling pathway},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110595}
}
EUVIMED